Skip to main content

. 1984 Feb;37(2):228. doi: 10.1136/jcp.37.2.228-a

Clinical versus laboratory strains of Group B streptococci and human neutrophil chemiluminescence.

M J Kowolik, C G Cumming

PMCID: PMC498684 PMID: 6363457

228

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Easmon C. S., Cole P. J., Williams A. J., Hastings M. The measurement of opsonic and phagocytic function by Luminol-dependent chemiluminescence. Immunology. 1980 Sep;41(1):67–74. [PMC free article] [PubMed] [Google Scholar]
Hastings M. J., Easmon C. S. Variations in the opsonic requirements of group B streptococcus type III. Br J Exp Pathol. 1981 Oct;62(5):519–525. [PMC free article] [PubMed] [Google Scholar]
Prade M., Sancho-Garnier H., Cesarini J. P., Cochran A. Difficulties encountered in the application of Clark classification and the Breslow thickness measurement in cutaneous malignant melanoma. Int J Cancer. 1980 Aug;26(2):159–163. doi: 10.1002/ijc.2910260206. [DOI] [PubMed] [Google Scholar]
Shigeoka A. O., Hall R. T., Hill H. R. Strain specificity of opsonins for group B streptococci types II and III. Infect Immun. 1979 Feb;23(2):438–445. doi: 10.1128/iai.23.2.438-445.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES